Indiana Business Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Indiana Business Reporter.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 7, 2025

December 7, 2025

CAPHRA Raises Alarm over Legitimacy of WHO Tobacco Treaty.

GlobeNewswire

December 7, 2025

WPP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that WPP plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire

December 7, 2025

MRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marex Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire

December 7, 2025

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:00 a.m. ET

GlobeNewswire

December 7, 2025

Kessler Topaz Meltzer & Check, LLP Reminds StubHub Holdings, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit

GlobeNewswire

December 7, 2025

Nayax Considering an Offering of Notes and Warrants in Israel

GlobeNewswire

December 7, 2025

Real Estate Expert Kerry Ramage of Melbourne, FL, Breaks Down Home Sale Strategy for HelloNation

GlobeNewswire

December 7, 2025

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

GlobeNewswire

December 7, 2025

ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with Indolent B-cell Non-Hodgkin Lymphoma, at ASH Annual Meeting

GlobeNewswire

December 7, 2025

Mutuum Finance (MUTM) Approaches 100% Presale Sellout Amid Ongoing Halborn Security Review

GlobeNewswire

December 7, 2025

Manufacturing Expert James Gizzi of Rochester Discusses How to Choose a CNC Machine Shop in HelloNation

GlobeNewswire

December 7, 2025

How Roofing Expert Tom Meadows of Ann Arbor Explains Roof Repair vs. Roof Replacement for HelloNation

GlobeNewswire

December 7, 2025

ARE INVESTOR LOSSES: Lose Money on Alexandria Real Estate Equities, Inc.? Contact BFA Law before January 26 Securities Class Action Deadline

GlobeNewswire

December 7, 2025

FCX INVESTOR LOSSES: Lose Money on Freeport-McMoRan Inc.? Contact BFA Law before January 12 Securities Class Action Deadline

GlobeNewswire

December 7, 2025

INSP INVESTOR LOSSES: Lose Money on Inspire Medical Systems, Inc.? Contact BFA Law before January 5 Securities Class Action Deadline

GlobeNewswire

December 7, 2025

JEF INVESTOR LOSSES: Lose Money on Jefferies Financial Group Inc.? Contact BFA Law about its Securities Fraud Investigation

GlobeNewswire

December 7, 2025

KMX INVESTOR LOSSES: Lose Money on CarMax, Inc.? Contact BFA Law before January 2 Securities Class Action Deadline

GlobeNewswire

December 7, 2025

LRN INVESTOR LOSSES: Lose Money on Stride, Inc.? Contact BFA Law before January 12 Securities Class Action Deadline

GlobeNewswire

December 7, 2025

SNPS INVESTOR LOSSES: Lose Money on Synopsys, Inc.? Contact BFA Law before December 30 Securities Class Action Deadline

GlobeNewswire

December 7, 2025

MLTX INVESTOR LOSSES: Lose Money on MoonLake Immunotherapeutics? Contact BFA Law before December 15 Securities Class Action Deadline

GlobeNewswire